The van Geest Foundation Heart and Cardiovascular Diseases Research Fund 2025: Easycardiogram: refinement of an ultra-low-cost heart rhythm monitoring prototype, , £21.6k, (PI).
ICURe Exploit 2025: EasyCardiogram: Developing a low-cost home ECG kit for remote monitoring and wider screening, £20k,(PI).
ICURe Explore 2024: EasyCardiogram: Developing a low-cost home ECG kit for remote monitoring and wider screening, £35k,(PI).
ICURe Discover 2024,EasyCardiogram: Developing a low-cost home ECG kit for remote monitoring and wider screening, £2.5k,(PI).
BHF Accelerator ECR Interdisciplinary Fellowship : LifeMap-VR: utilizing virtual reality for enhanced cardiac stress testing and risk stratification for sudden cardiac death. 2023/24, £63k (PI).
MRC IAA Funding: Bench testing and refinement of an ultra-cost-effective heart rhythm monitoring solution prototype. 2023/24, £66k (PI).
National Institute for Health Research: - LifeMap – Quality-assurance User-focussed Evaluation of Safety and Tolerability (LifeMap-QUEST, NIHR204553) : developing LifeMap-Vest and LifeMap-Compute for exercise assessment with optimised digital ECG recording for sudden death risk stratification. £ 840k 2023/25 (CI)
Knowledge Exchange, Impact and Proof of Concept Fund 2022-23. £4k, 2023 (PI)
LD3 MRC IAA Funding: Developing an ultra-low-cost heart rhythm monitoring solution for remote consultations and telemedicine using peripheral attachments to smart phones, PCs or tablets. 2022, £72k (PI).
Knowledge Exchange Impact and Proof of Concept fund: Towards utilising a novel non-invasive test for risk stratification for sudden cardiac death. 2022. £5.5k (CI).
The van Geest Heart and Cardiovascular Diseases Research Fund. "Deep learning methods for early detection of myocardial ischemia using digital and paper ECGs", 2020/21, £11.8k (PI)
MRC Confidence in Concept funds 2020 (Leicester Drug Discovery and Diagnostics (LD3)): Optimising deep neural networks for fully automating a novel technology for risk stratification of sudden cardiac death. 2020/21. £43k (CI)
ECR and research staff funding - Doctoral College - Short-term visiting grants, 2019. £4k (PI)
IAX Events and Meetings Funding. ‘’Industrial meeting: Intelligent systems for target identification of catheter ablation in atrial fibrillation’’ 2019. £1k (PI)
Biomedical Catalyst DPFS Developmental Pathway Funding (MR/S00582X/1). ‘’Development of a successful novel technology for sudden cardiac death risk stratification for clinical use – LifeMap’’ 2019/22. £1m (NC)
British Heart Foundation Project Grant (PG/18/33/33780). “Improving target identification for catheter ablation using dominant frequency and rotor analysis in human persistent atrial fibrillation using non-contact mapping” 2018/20. £93k (NC)
MRC Confidence in Concept funds 2019 (Leicester Drug Discovery and Diagnostics (LD3)): Deep learning for refining LifeMap - a new technology for risk stratification of sudden cardiac death, 2019/20. £43k (CI)
MRC Confidence in Concept funds 2017 (Leicester Drug Discovery and Diagnostics (LD3)): Towards commercialising LifeMap as a novel clinical tool for assessing risk of sudden cardiac death, 2017/18. £42k (NC)
MRC Proximity to Discovery (P2D): Adhoc Industry Engagement Activities. Improving efficacy of catheter ablation for atrial fibrillation, 2016/17. £3k (PI)
Journal Paper selected as Editor's Choice - Computer Methods and Programs in Biomedicine - April 2017 - An interactive platform to guide catheter ablation in human persistent atrial fibrillation using dominant frequency, organization and phase mapping.
Young Investigator Competition Finalist at Heart Rhythm Congress 2017 “Characteristics of Ablated Rotors in Terminating Persistent Atrial Fibrillation using Non-Contact Mapping”, Xin Li, Gavin S Chu, Tiago P Almeida, João L Salinet, Nawshin Dastagir, Amar R Mistry, Zakariyya Vali, Peter J Stafford, Fernando S Schlindwein, G André Ng
*(PI: principle investigator; CI: co-investigator; NC: named candidate)